Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 6
Submit an article Journal homepage
204
Views
1
CrossRef citations to date
0
Altmetric
Hematology

Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants

Darko Mitrovica Department of Hospital Pharmacy, Tjongerschans, Heerenveen, The NetherlandsCorrespondence[email protected]
,
Margriet van Elpa Department of Hospital Pharmacy, Tjongerschans, Heerenveen, The Netherlands
,
Loes Visserb Department of Hospital Pharmacy, Haga Hospital, The Hague, The Netherlands
,
Nienke van Reinc Department of Hospital Pharmacy, University Medical Centre Leiden, Leiden, The Netherlands
,
Patricia van den Bemtd Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands
,
Marinus van Hulste Department of Hospital Pharmacy, Martini Hospital Groningen, Groningen, The Netherlands;f Department of Hospital Pharmacy, Treant Hospital Emmen, Emmen, The Netherlands
,
Albert Dreijerg Department of Hospital Pharmacy, Treant Care Group, Hoogeveen, The Netherlands
,
Heleen Lameijerh Department of Emergency Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
,
Nic Veegeri Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;j MCL Academy Medical Centre Leeuwarden, Leeuwarden, The Netherlands
,
Karina Meijerk Department of Haematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
&
Eric van Roonl Department of Pharmacotherapy, Epidemiology and Economy, Faculty of Pharmacy, University of Groningen, Groningen, The Netherlands;m Department of Clinical Pharmacy, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
 show all
Pages 865-871 | Received 29 Dec 2022, Accepted 17 Apr 2023, Published online: 28 Apr 2023

References

  • Huisman MV, Fanikos J. Idarucizumab and factor Xa reversal agents: role in hospital guideline and protocols. J Am Med. 2016;12(11):89–96.
  • Godier A, Bacus M, Kipnis E, et al. Compliance with evidence -based clinical management guidelines in bleeding trauma patients. Br J Anaesth. 2016;117(5):592–600.
  • Rice TW, Morris S, Tortella BJ, et al. Deviations from evidence-based clinical management guidelines increase mortality in critically injured trauma patients. Crit Care Med. 2012;40(3):778–786.
  • Shafi S, Barnes SA, Rayan N, et al. Compliance with recommended care at trauma centers: associations with patient outcomes. J Am Coll Surg. 2014;219(2):189–198.
  • Cotton B, Dossett LA, Au BK, et al. Room for (performance) improvement: provider-related factors associated with poor outcomes in massive transfusion. J Trauma. 2009;67:1004–1012.
  • Bawazeer M, Ahmed N, Izadi H, et al. Compliance with a massive transfusion protocol (MTP) impacts patient outcome. Injury. 2015;46(1):21–28.
  • Cuker A, Burnett A, Triller D, et al. Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol. 2019;94(6):697–709.
  • Mitrovic D, Stapel L, Veeger N, et al. Protocolized management of bleeding in hospitals in The Netherlands in patients treated with direct oral anticoagulants. Curr Med Res Opin. 2023;39(1):71–79.
  • Mitrovic D, van Elp M, Veeger N, et al. Protocols for perioperative management of direct oral anticoagulants in hospitals: opportunities for improvement. Curr Med Res Opin. 2023;39(1):13–18.
  • Kaatz S, Ahmad D, Spyropoulos AC, et al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and veneous thromboembolism disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–2126.
  • Barillari G, Pasca S, Barillari A, et al. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. Blood Transf. 2012;10(1):87–94.
  • Toth P, van Veen JJ, Robinson K, et al. Real world usage of PCC to ``rapidly``correct warfarin induced coagulopathy. Blood Transf. 2013;11:500–505.
  • Van der Wall SJ, van Rein N, van den Bemt B, et al. Performance of idarucizumab as antidote of dabigatran in daily clinical practice. Europace. 2019;21(3):414–420.
  • Fanikos J, Murwin D, Gruenenfelder F, et al. Global use of idarucizumab in clinical practice: outcomes of the RE-VECTO surveillance program. Thromb Haemost. 2020;120(1):27–35.
  • Sobolewski KA, Brophy A, Choi SC, et al. Real-world observational review of andexanet alfa prescribing and utilization outcomes at a community teaching hospital. Crit Care Explor. 2021;3(4):e0356.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.